Stockholders' Equity (Details) - USD ($)			1 Months Ended				3 Months Ended
	Feb. 10, 2021	Dec. 09, 2020	Jan. 31, 2021	Jan. 27, 2021	Jan. 26, 2021	Jan. 21, 2021	Mar. 31, 2021	Dec. 31, 2020
Stockholders' Equity (Details) [Line Items]
Preferred stock, shares authorized							100,000,000	100,000,000
Common stock, shares authorized							300,000,000	300,000,000
Common stock, shares issued							66,308,177	49,444,689
Additional purchase of securities, description	In addition, pursuant to the Second Offering Underwriting Agreement, the Company granted the Representative a 45-day option to purchase up to 847,058 additional shares of common stock to cover over-allotments in connection with the Second Offering, which the Representative exercised in full on February 11, 2021.				the Company granted the Representative a 45-day option to purchase up to 578,312 additional shares of common stock, and/or 578,312 additional First Offering Warrants, to cover over-allotments in connection with the First Offering, which the Representative partially exercised to purchase 578,312 Warrants on the First Offering Closing Date. For additional information on these First Offering Warrants, see Note 18 – Share-Based Compensation.
Gross proceeds received (in Dollars)	$ 27,600,000			$ 1,365,000
Gross proceeds deduction, percentage	8.00%			8.00%		8.00%
Representative warrants to purchase of shares of common stock	225,882			154,216
Common stock, par value (in Dollars per share)							$ 0.0001	$ 0.0001
Warrants to purchase shares of common stock	198,776
Description of consulting agreement			the Company entered into an agreement with a consultant to replace an existing consulting agreement between the consultant and the Company to allow the consultant to elect to take from 50% to 100% of its compensation in the form of common stock based on an agreed upon conversion calculation. Any difference between the amount due and the actual fair value of the shares issued in payment is recorded as general and administrative expense in the Company’s Condensed Consolidated Financial Statements. Common stock to be issued to the consultant will be paid on a quarterly basis. On March 12, 2020, the Company issued 55,032 shares of its common stock in satisfaction of $106,238 that was owed by Lextrum to the consultant for services previously rendered. The fair value on the issue date of the 55,032 shares of common stock was $193,160. As of March 31, 2021, 7,571 shares of common stock, with a fair value of $20,215, are recorded as unissued shares, as discussed below, for services rendered for the first quarter of the 2021 fiscal year.
Consultant payment of common stock		5,000
Fair value of amount (in Dollars)		$ 30,750
Common stock of vested								2,125
Common stock of expense (in Dollars)								$ 13,069
Remaining shares of vested							2,875
Additional recognized expense (in Dollars)							$ 17,681
Unissued shares							7,571
Vendor [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, par value (in Dollars per share)				$ 4.15
First Offering [Member]
Stockholders' Equity (Details) [Line Items]
Sale of aggregate units of shares					3,855,422
Sale of stock, price per unit (in Dollars per share)					$ 4.15
Common stock exercise price (in Dollars per share)					$ 4.50
Gross proceeds received (in Dollars)						$ 16,000,000
Purchase of additional shares of common stock				329,815
Sale of common stock, percentage				4.00%
Total expenses of public offering (in Dollars)				$ 2.7
Second Offering [Member]
Stockholders' Equity (Details) [Line Items]
Sale of aggregate units of shares	5,647,059
Sale of stock, price per unit (in Dollars per share)	$ 4.25
Sale of common stock, percentage	4.00%
Total expenses of public offering (in Dollars)	$ 2.6
Private Placement [Member]
Stockholders' Equity (Details) [Line Items]
Warrants to purchase shares of common stock	27,106
Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Warrants issued				100,000